The designated DNDI assay, which involves testing for cytotoxicity against human MRC-5 lung fibroblast cells, is assigned to a non-molecular target. This assay specifically utilizes MRC5 cells as the assay cell type and Homo sapiens as the assay organism. Furthermore, the assay test type is conducted in vitro, and falls under the category of toxicity assay type description. Based on the criteria set forth for this assay, would it be accurate to conclude that the molecule in consideration is efficacious?